PTC Therapeutics provided a brief update on the Formal Dispute Resolution Request process for ataluren.
Read the update from PTC:
Dear Duchenne Community,
As we enter the holiday season, I wanted to thank the community for all your support throughout the regulatory process for Translarna™ (ataluren) with the FDA. Your voice as passionate advocates has been instrumental in this process. As you k…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this